Pasithea Therapeutics (KTTA) Treasury Shares (2021 - 2023)

Pasithea Therapeutics' Treasury Shares history runs 3 years deep, the most recent figure standing at $266171.0 for Q4 2023.

• In Q4 2023, Treasury Shares fell 91.7% year-over-year to $266171.0; the TTM figure through Dec 2023 stood at $266171.0 (down 91.7% YoY), while the FY2023 annual figure was $266171.0, down 91.7% from the prior year.
• Treasury Shares came in at $266171.0 for Q4 2023 at Pasithea Therapeutics, roughly flat from $266171.0 in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $3.2 million in Q4 2022 to a low of $10000.0 in Q4 2021.
• A 3-year average of $936906.0 and a median of $266171.0 in 2023 frame the typical range for Treasury Shares.
• Across the five-year window, Treasury Shares jumped 31952.82% in 2022 and slumped 91.7% in 2023, its largest moves.
• Pasithea Therapeutics' Treasury Shares stood at $10000.0 in 2021, then surged by 31952.82% to $3.2 million in 2022, then sank by 91.7% to $266171.0 in 2023.
• According to Business Quant data, Treasury Shares over the past three periods registered $266171.0, $266171.0, and $3.2 million for Q4 2023, Q3 2023, and Q4 2022 respectively.

Peer Comparison